Adaptiiv
Founded: 2017
Headquarters: 1969 Upper Water Street, Suite 906, Halifax, Nova Scotia B3Z1M6, CA
Phone: 902-442-9091
Number of employees: 11-50
Website: www.adaptiiv.com
Overview
Adaptiiv Medical Technologies, Inc., a global pioneer in developing advanced 3D printing solutions for the medical sector, focuses on revolutionizing patient care in radiation oncology, medical physics, and cancer treatment. Established in 2017, the Halifax, Nova Scotia-based company aims to advance healthcare applications through 3D printing technology, enhancing treatment quality and effectiveness.
The company’s founding members, experienced professionals in medical physics, radiation oncology, and software development, recognized 3D printing’s potential in transforming radiation therapy for cancer patients. By striving for better treatment outcomes and reduced side effects, Adaptiiv has concentrated on creating state-of-the-art software solutions for patient-specific, 3D-printed medical devices in radiation therapy.
Adaptiiv’s flagship product, 3D Bolus, exemplifies the company’s innovation in patient care. This groundbreaking software enables healthcare providers to design and print customized radiation-absorbing boluses using a 3D printer. 3D Bolus technology ensures accurate radiation dose delivery to tumors, minimizing exposure to surrounding healthy tissue. This personalized approach improves treatment efficacy, planning time, and patient comfort.
The company’s success is evident through multiple funding rounds, including a 2017 seed round and a 2018 Series A funding round, which raised $1.8 million. Led by First Angel Network, Innovacorp, and other private investors, these funds facilitated Adaptiiv’s global expansion and reinforced its medical 3D printing market leadership.
In 2019, Adaptiiv announced a strategic partnership with CIVCO Radiotherapy, a global radiation oncology patient positioning and immobilization solution leader. This collaboration aimed to increase Adaptiiv’s 3D printing solution adoption by leveraging CIVCO’s extensive distribution network and industry expertise. This partnership enabled the company to enter new markets and solidify its position as a medical 3D printing industry leader.
Adaptiiv’s dedication to innovation has garnered several awards and recognitions, including the 2018 Nova Scotia Export Achievement Award for New Exporter of the Year and being named as one of the “Top 10 Radiation Oncology Solution Providers” by MedTech Outlook in 2019.
Adaptiiv’s robust intellectual property portfolio, including multiple patents related to 3D printing technology and software solutions, ensures a competitive edge in the rapidly evolving market. The strategic partnership with CIVCO Radiotherapy and the company’s successful funding history position Adaptiiv for potential acquisitions or future collaborations with larger medical technology industry players.
In addition to product offerings, Adaptiiv contributes to research and education advancements in radiation oncology and medical physics by partnering with top healthcare institutions and research organizations. These collaborations validate the clinical benefits of Adaptiiv’s solutions and facilitate the development of new applications and improved cancer treatment methods.
In summary, Adaptiiv Medical Technologies is a trailblazer in medical 3D printing, with a focus on radiation oncology and patient-specific solutions. With significant capital, product expansion, and valuable industry partnerships, Adaptiiv is well-positioned to continue its growth in the medical technology industry. The company’s strong intellectual property portfolio and innovative reputation will likely maintain its role as a key player in developing and implementing cutting-edge, 3D-printed medical solutions for cancer treatment.
Disclaimer: Please note that the names and positions of employees mentioned may be subject to change, as individuals may move to different roles or organizations. While we make every effort to keep our information accurate and up-to-date, we cannot guarantee that all employee details are current or complete. We encourage you to verify the identity and positions of any individual mentioned and check their Linkedin Profile before taking any action based on their role.